| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 11/14/2006 | US7135473 Cyclic diamine compound with condensed-ring groups |
| 11/14/2006 | CA2274669C 1,5-benzodiazepine derivatives |
| 11/14/2006 | CA2128955C Tricyclic benzazepine vasopressin antagonists |
| 11/09/2006 | WO2006117672A2 Detection of ortho-diamine residues in analytes containing residual cyclizing agents |
| 11/09/2006 | CA2606664A1 Detection of ortho-diamine residues in analytes containing residual cyclizing agents |
| 11/08/2006 | EP1021190B1 Amid derivatives as growth hormone release promotors |
| 11/08/2006 | CN1283639C Pirenzepine organic acid salt and eye drops for treating myopia |
| 11/07/2006 | CA2244777C 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 11/01/2006 | CN1856313A Therapeutic compounds |
| 10/31/2006 | US7129228 Heterocyclic analgesic compounds and methods of use thereof |
| 10/26/2006 | WO2006111371A1 Pharmaceutically active diazepanes |
| 10/26/2006 | US20060241113 Polyarylcarboxamides useful as lipid lowering agents |
| 10/26/2006 | DE102005017116A1 Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) Inhibitors of inhibitors of apoptosis proteins (IAP) |
| 10/26/2006 | CA2600774A1 Pharmaceutically active diazepanes |
| 10/25/2006 | CN1850808A Non oxaza organics and their use |
| 10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
| 10/24/2006 | US7125866 Therapeutic applications of pro-apoptotic benzodiazepines |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/19/2006 | WO2006110198A1 Seven-membered heterocyclic carbenes and their metal complexes |
| 10/19/2006 | WO2006049984A3 Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/19/2006 | US20060235007 Substituted 1,4-diazepines and uses thereof |
| 10/19/2006 | CA2604202A1 Seven-membered heterocyclic carbenes and their metal complexes |
| 10/18/2006 | EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds |
| 10/18/2006 | EP1711470A1 Malonamide derivatives blocking the activtiy of gamma-secretase |
| 10/18/2006 | EP1711463A2 Amino-substituted tricyclic derivatives and methods of use |
| 10/18/2006 | CN1849308A Thiophenylaminoimidazolines |
| 10/18/2006 | CN1849121A Piperazine derivatives as bradyknin antagonist |
| 10/18/2006 | CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 10/17/2006 | US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 10/17/2006 | US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS |
| 10/12/2006 | WO2006106241A1 Piperazine derivatives and use thereof as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/12/2006 | US20060229448 as nucleophilic catalysts use in asymmetric catalysis |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | US20060229297 (THIO) Carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 10/11/2006 | EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/11/2006 | CN1279044C Non-steroidal progesterone receptor modulators |
| 10/11/2006 | CN1279029C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 10/10/2006 | US7119196 Anxiolytic agents with reduced sedative and ataxic effects |
| 10/10/2006 | US7119180 Halogenation with a diphenylhalosulfonimide, deblocking the protected hydroxyl group; optional esterification or addition salt formation |
| 10/10/2006 | CA2240196C Process for the preparation of (meth)acrylic acid esters |
| 10/05/2006 | WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | WO2006065826A3 Process to chiral beta amino acid derivatives by asymmetric hydrogenation |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | CA2602546A1 Novel compounds |
| 10/05/2006 | CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/04/2006 | EP1706371A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 10/04/2006 | CN1840527A Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/03/2006 | US7115598 antagonist to tumor suppression gene ; controlling cell proliferation |
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/26/2006 | US7112583 Containing a benzodiazepine ring, e.g., (2(R)-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; treating Alzheimer's disease and Down's Syndrome |
| 09/21/2006 | WO2006097449A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | US20060211682 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/21/2006 | US20060211681 Adenosine deaminase inhibitor and novel bacillus sp. iada-7 strain which produces it |
| 09/21/2006 | US20060211679 Substituted lactams as inhibitors of Abeta protein production |
| 09/21/2006 | CA2600521A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 09/19/2006 | US7109326 Peptide mimetics, bioconvertable prodrug |
| 09/14/2006 | US20060205714 Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof |
| 09/14/2006 | US20060205696 [[2-(Amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199808 Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof |
| 09/06/2006 | EP1697332A1 Benzo'1,4 ! diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 09/06/2006 | CN1829703A (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 09/05/2006 | US7101872 Farnesyl dibenzodiazepinone, and processes for its production |
| 09/05/2006 | US7101871 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/05/2006 | US7101870 2R,3S) N1-[6,7-dihydro-5-(3-phenoxybenzyl)-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; treating Alzheimer's disease and Down's Syndrome by inhibiting production of A beta -peptide |
| 08/31/2006 | WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 08/31/2006 | US20060194961 cost efficiency; environmentally friendly |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/29/2006 | US7098200 Analgesics |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/23/2006 | EP1692126A1 Reactive cyclic carbonates and ureas used for modifying biomolecules, polymers, and surfaces |
| 08/23/2006 | EP1692110A1 Diacylhydrazine derivatives |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/17/2006 | WO2006085096A1 Ligands for g-protein coupled receptors |
| 08/17/2006 | WO2006044753A3 Chemical compounds |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 08/17/2006 | CA2597481A1 Ligands for g-protein coupled receptors |
| 08/16/2006 | EP1689493A1 Calcitonin gene related peptide receptor antagonists |
| 08/16/2006 | CN1269818C Lactam compounds and medicinal use thereof |
| 08/15/2006 | US7090703 oxidation base hair dye; nontoxic, colorfast |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/09/2006 | EP1687288A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 08/09/2006 | EP1537114B1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/09/2006 | CN1268626C Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/03/2006 | WO2006081332A1 Substituted arylamine compounds and their use as 5-ht6 modulators |
| 08/03/2006 | WO2006065479A3 Substituted phenols as active agents inhibiting vegf production |
| 08/03/2006 | WO2006055381A3 Prodrugs of (2r)-2-propyloctanoic acid for treatment of stroke |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | US20060172395 Enriched nucleic acid comprising a nucleotide complementary sequence, encoding a polypeptide from:an adenylating amide synthetase or an isoprenyl transferase |
| 08/03/2006 | CA2595607A1 Substituted arylamine compounds and their use as 5-ht6 modulators |
| 08/02/2006 | EP1565473B1 N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |